Control group:Placebo + ranibizumab
Sponsors
Eye Hospital, China Academy of Chinese Medical Sciences
Conditions
Neovascular age-related macular degeneration
Early Phase 1
Mingjing Granule in the treatment of neovascular age-related macular degeneration: a prospective, randomized, double-blind, placebo parallel controlled, multicenter clinical trial
Active, not recruitingITMCTR2000003625
Start: 2020-10-01Updated: 2023-02-20
Mingjing Granule in the treatment of neovascular age-related macular degeneration: a prospective, randomized, double-blind, placebo parallel controlled, multicenter clinical trial
Active, not recruitingChiCTR2000035990
Start: 2020-10-01Updated: 2020-09-07